Oxford Nanopore Technolo... Share Discussion Threads

[74tom] 19/4/2024 10:28

That was the scope of the initial partnership announced last April, the October expansion in which they made their £70m investment broadened things to;

"The investment strengthens the relationship between the two companies, further aligning with Oxford Nanopore's increasing focus on clinical markets through a partnership announced in April this year. This investment will support development for products in Oxford Nanopore's portfolio to serve IVD markets in conjunction with bioMérieux's commitment to advancing global public health."

&

"Together, the companies are driving to meet a significant unmet need in the clinical and diagnostic markets- an opportunity where nanopore sequencing is uniquely suited to deliver impact where information-rich, rapid, accessible, and affordable sequencing are critical."

[ih_828197] 19/4/2024 09:47

i thought Bio Merieux partnership was focused on in vitro diagnostic (IVD) solutions only, good to know they are expanding it.

[bamboo2] 19/4/2024 08:01

bio Merieux partnership event in the area of food safety.

This webinar will delve into the impact of real-time nanopore sequencing on food safety — including quality assurance — within the public and private sectors. Food microbiologists will share how new genomic tools can help create a safer and more digital, traceable food system, as outlined in the FDA’s blueprint for a New Era of Smarter Food Safety.

[brucie5] 18/4/2024 17:47

Well I've stated mine.

[ih_828197] 18/4/2024 17:26

What's your guys average price? (If you don't mind sharing) I'll start with mine: 137p, but it will go down as paychecks arrive :)

[brucie5] 18/4/2024 17:06

p1nkfish18 Apr '24 - 16:53 - 1303 of 1303
0 0 0
Taking part is not compulsory.
---------------------------------------------------------------------------------
I couldn't agree more. I have to confess I was a little excited to see the long awaited sub £1 arrive. And I have absolutely no knowledge in my possession that says it won't fall below 90p. But the only thing that has really changed is B/E being pushed out by a year, while the IP and product line gets ever more entwined in all sorts of medicine and research. So i think this will only become more valuable, though it might take them some time to persuade the market that it is a business as well as a technology.

Meantime, come back in two years time we might be having the same conversation, but the cash runway will still be sufficient and the story will only have grown.

As stated, I now have full holding which I feel reasonably confident to hold to term. This could of course be a TO, as easily as a business to be valued at many billions in due course. In fact, given the ongoing state of the markets, much more easily - unless it decamps to the US.

And at an average price of a couple of pennies above where we are now.

I will now shut up until we have further new to discuss, or someone contributes something on which I'd like to comment.

The next days might prove interesting - either way.
;)

[p1nkfish] 18/4/2024 16:53

I don't see the need to rush. Traders might be OK but non-traders better off waiting for confirmation that a turn-around is taking hold and in the meantime sit it out. Some have probably been slaughtered here. Who can guarantee the date of a longer term price reversal? First people are stripped of their capital, next they are made to wait for who knows how long for any signs of hope. Both phases are unpleasant. Taking part is not compulsory.

[brucie5] 18/4/2024 16:04

I hope noone sold today... Looks like an attack on the share price has been thwarted. Same again tomorrow? Or will we have new holders on board.
If it can't be pushed below 90p, then £1 is the next obvious threshold. I imagine there will be quite a few new conviction buyers here.

[brucie5] 18/4/2024 14:19

Thanks guys. All grist to the mill.
15.39. Looks like a battle of the Alamo down here.
Better put on my David Crocket hat.
😉

[ih_828197] 18/4/2024 13:51

H2 of this year is when i think the turn-around will happen and the path to profitability will become clearer until then i'll keep avaraging down, ONT reminds me of PLTR 2 years ago, great tech but the market had no confidence on future growth and managment and we know how that turned out.

[74tom] 18/4/2024 13:00

There are no declared positions above the 0.5% threshold right now, although JP Morgan went above that level back in Jan & Millenium were short above that level for a while in 2022. As I said on the KWS board last week, the LSE short reporting disclosures are a disgrace and unfit for purpose vs other global exchanges (NASDAQ & TSX have twice monthly cumulative reporting, ASX daily cumulative). My guess would be that cumulative short positions in ONT are ~5% of share capital (Pacbio was 19% at 28/03). It could be significantly higher, but volume hasn't really been sufficient for that & GIC Private (the Singapore sovereign wealth fund) have been heavy sellers.

Agree on questioning the business model, and I think management should be reporting quarterly to keep shareholders up to date on progress, which is of course the norm in the US, Australia & Canada...

[takeiteasy] 18/4/2024 12:45

just to clarify is this being actively shorted, once we get this low you start to wonder if the entire business model is being questioned as viablequestion is there anything management can do more to more to address this

[74tom] 18/4/2024 12:41

@brucie, there were a couple of 50k buys on the book in the 93/94 region, they've now been filled & now we have 50k at 90.1 and 45k at 88, both placed in the last half an hour

[74tom] 18/4/2024 12:39

Volume simply isn't there at the moment, sellers still offloading into a buy side order book that is unchanged from the last few months, a few 50k blocks every now and again but nothing resembling true support (I'd want to see 7 figure buy orders propping things up to signal a potential bottom).

Personally, I don't think there is any definitive read across from PACB's strategic & financial problems, however given the worsening macro it appears that this has become even more of a 'show me' story, and the value of the IP has gone out of the window for now.

Very interesting to see just how low this ends up going, PACB has certainly thrown fuel on the fire for those who don't believe long reads can commercially replicate the success that Illumina had on the short read side.

[brucie5] 18/4/2024 12:31

Someone appears to be hoovering at 93/94.

[brucie5] 17/4/2024 16:48

Decent recovery, but sub £1 may yet be tested again tomorrow to see how far down this can be taken. The more resilient the support over 90p, the higher the bids may become. I cannot see this as a penny share for long. But maybe that's wishful thinking.

[brucie5] 17/4/2024 14:37

One illustration of the mcap/revenue differential between three pre-profit stories I follow:

Mcap Revenues Rev Multiple

OXB 195 119 1.6

ONT 861 169 5

CWR 257 22 11

All figures from Stocko. I hold 1 & 2 in order of size; but not yet 3.

[brucie5] 17/4/2024 11:45

Maybe a good call, Yas; this is what I thought would happen, with 90p as possible support after £1.
Though who knows.
Too much to expect some major buying at this level?

[yasx] 17/4/2024 11:06

Have started to scale in here, will add on any further declines.

[p1nkfish] 16/4/2024 17:41

4.5x 3M average volume on PACB already and still 3.5 hrs left approx.

If PACB looks so risky would you want to adopt their solutions unless there was no alternative? Needs some deep pockets to step in to stabilise their ship.

Worth waiting to see a sign of reverse in trend before taking any positions.

[74tom] 16/4/2024 17:28

Didn't know that @bamboo2, but it makes sense when you look at their consumables performance over the last few years, it looks like many customers never order beyond the free stuff either... horrendous financials.

As for the UK listing being a shelter, it doesn't really work when a company is on SETS as ONT is, there was huge sell volume in the closing auction which almost pushed the price under £1. Agree on the US market in general though, there are some nosebleed valuations again after the relative reset in 2022

[brucie5] 16/4/2024 17:09

£1 hit. Now let's see.

[p1nkfish] 16/4/2024 16:57

Have to wonder if a UK listing is not so bad after all.
A backwater away from the US slaughter house.

US multiples will come under the hammer and some reality begin to sink in across multiple sectors.

Keep away from areas where much of the upside has been down to P/E expansion.

[bamboo2] 16/4/2024 16:51

74tom, PACB also robs its forward sales of consumables by packaging a load of them 'free' if new customers order a new machine. Aka 'buying the business'.